2018, and 2017 were 3.74% and 1.40% respectively. The 1st Quarter of 2018 revenue 16.65 million baht, 1st Quarter of 2017 revenue 7.00 million baht. The 1st quarter of 2018 increased from the 1st quarter

also increased. The revenues for the Company only were 4,864 million baht, increasing by 669 million baht or 16% from last year and 2% from the previous quarter. As of May 31, 2018, The Company has

), toll revenue was slightly decreased from the previous year. For the Bang Pa-in - Pak Kret Expressway (Sector C+), toll revenue increased by 3.1 percent due to the expansion of suburban area resulting to

Company had operating loss before financial costs and income tax of 971 million Baht (89% of total revenues). The operating loss increased by 38% as compared to the same period last year of a loss of 704

, 2020 3 Cost of service increased from the same quarter of the previous year by Baht 44 Million or 1.8 percent mainly from the expenses related to the operation of the MRT Blue Line Extension Section 2

6.9% YoY, as a result of the adoption of TFRS16, which increased lease liability in 1Q2020 by Bt164.00mn. Total shareholders’ equity was Bt1,096.62mn, decreasing 17.9% YoY, as a result of the 1Q2020 net

lawsuit issue increased Baht 1.28 million. Loss Attributable to Equity Holders of the Company In 2019, there was a loss attributable to equity holders of the company of Baht 277.59 million, whereas Baht

%. Mainly from the revenues of booking and contracts cancellation. Nevertheless, the revenues from the property management was increased which correspond to the increase of project under company’s management

that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of

revenue or THB 328mn decreasing by 1.5% YoY. Cost of sales decreased from THB 482mn to THB 466mn or THB 16mn due to the exercise of assets optimisation in the last quarter. Cost-to-sales ratio increased